<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03010007</url>
  </required_header>
  <id_info>
    <org_study_id>Influenza in Basel 2016/2017</org_study_id>
    <nct_id>NCT03010007</nct_id>
  </id_info>
  <brief_title>Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland</brief_title>
  <official_title>Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland [Prospektive Systemanalyse Der Saisonalen Influenza - Virustransmission Und Evolution in Der Stadt Basel] in German</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Children's Hospital Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Influenza associated illness has a global annual impact with high morbidity and mortality.&#xD;
      Transmission mechanisms and rates are under-investigated and overall poorly understood.&#xD;
&#xD;
      This project aims to use epidemiological tools to understand the transmission and evolution&#xD;
      of influenza viruses at an individual and population level within a small-scale city (Basel)&#xD;
      through a combination of experimental, clinical and mathematical advances. The investigators&#xD;
      aim to quantitatively characterize the viral transmission using novel&#xD;
      molecular-epidemiological tools based on whole genome sequencing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective observational study, paediatric and adult outpatients presenting with&#xD;
      influenza-like illness will be enrolled at the emergency departments of the University&#xD;
      Hospital Basel (USB), the paediatric University Hospital of both Basel (UKBB), or a network&#xD;
      of family doctors (associated with Center of Primary Health Care).&#xD;
&#xD;
      The Clinical Trial Unit at the University Hospital Basel will coordinated the recruitment&#xD;
      process, collect data and sample all patients during the influenza season 2016/17. Samples&#xD;
      will be collected such as whole blood, serum and DNA, nasopharyngeal swamps to diagnose&#xD;
      influenza by polymerase chain reaction (PCR) assay and to determine colonization rates with&#xD;
      Staphylococcus aureus and Streptococcus pneumonia. All samples except the first&#xD;
      naso-pharyngeal swab for influenza diagnostics will be stored in a biobank and analysed in&#xD;
      batches. Each influenza virus isolate will be sequenced using a &quot;whole genome sequencing&quot;&#xD;
      approach. The viral transmission and evolution will be analysed using whole genome data for a&#xD;
      detailed molecular and phylogenetic tree analysis, respectively. The epidemiological and&#xD;
      geographical data will be incorporated into the phylogenetic model.&#xD;
&#xD;
      Specific aims are:&#xD;
&#xD;
      (i) to determine the impact of the most important epidemiological parameters, first focusing&#xD;
      on the age profile, followed by children per house hold, and population density, on influenza&#xD;
      transmission at an individual and population level, drawing on an analysis of baseline&#xD;
      humoral immunity and whole genome sequencing data, (ii) to understand the viral evolution&#xD;
      during seasonal epidemics, (iii) to develop dynamic mathematical models that are able to&#xD;
      predict viral transmission and evolution based on the retrospective results from (i) and (ii)&#xD;
      and to validate this model in future influenza seasons.&#xD;
&#xD;
      To realize the interdisciplinary approach, the investigators will rely on the expertise in&#xD;
      mathematical modelling of viral epidemiology and evolution and established geographical&#xD;
      expertise, next generation sequencing, clinical epidemiology, and immunologic diagnostic&#xD;
      techniques.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Investigation of the phylogenetic relation of viral isolates from participating patients using whole-genome sequencing and bioinformatics</measure>
    <time_frame>Baseline</time_frame>
    <description>The primary microbiological endpoint is the connection of two viral isolates via comparison and phylogenetic analysis by using the genetic information</description>
  </primary_outcome>
  <enrollment type="Actual">800</enrollment>
  <condition>Influenza</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood (serum) and nasopharyngeal swabs&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Paediatric or adult patients fulfilling the World Health Organization (WHO) definition of&#xD;
        an influenza-like illness. A total number of 1000 influenza PCR-confirmed cases should be&#xD;
        included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Each pediatric or adult patient, which fulfill the Worl Health Organization (WHO)&#xD;
             definition of Influenza like illness.&#xD;
&#xD;
          -  The case definition includes an acute respiratory infection with coughing, fever&#xD;
             ≥38°C, and start of symptoms within the last 10 days.&#xD;
&#xD;
          -  Presentation of the patient with influenza-like illness on the emergency ward of the&#xD;
             University Hospital Basel or the University Children Hospital of both Basel or a&#xD;
             collaborating private practise.&#xD;
&#xD;
          -  Patient has to live in the city of Basel.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are not living in the City of Basel.&#xD;
&#xD;
          -  Case definition for influenza like illness is not fulfilled.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Egli, PD Dr. FAMH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Microbiology, University Hospital Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal Institute of Technology Zurich</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätres Zentrum für Hausarztmedizin beider Basel, University of Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 22, 2016</study_first_submitted>
  <study_first_submitted_qc>January 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2017</study_first_posted>
  <last_update_submitted>February 11, 2019</last_update_submitted>
  <last_update_submitted_qc>February 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Influenza</keyword>
  <keyword>High-Throughput Nucleotide Sequencing</keyword>
  <keyword>Viral Transmission</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

